Page last checked
Thymic immunomodulatory peptide (approved outside the United States) · safety
Thymosin alpha-1 side effects
The thymosin alpha-1 side effects reported most often are any side effect during treatment. The full list is below, with the cited trial report cited at the bottom of the page.
Rarer, but worth being able to spot: serious side effect and serious side effects attributed to the drug itself.
The sources describe these effects in relation to the dose and to the early weeks.
Thymosin alpha-1 is a peptide 28 amino acids long, first pulled out of calf thymus extract in the 1970s. It acts on how T cells mature and signal. It is sold for immune support: long COVID, chronic infection, and general resilience.
It carries a large trial record, and that record is about acutely unwell hospital patients rather than healthy adults. Under the name thymalfasin it is an approved medicine in several countries, mainly for chronic hepatitis B. Its largest trial gave it to 1,106 people with sepsis. By day 28, 23.4% had died on the drug against 24.1% on placebo.
At a glance
Common reactions listed
1
Serious reactions listed
2
Boxed warning
No label exists
Strongest source
limited human data
Common reactions
The full list, as reported across the available trial evidence. There is no approved label to read frequency bands off, so these are the trials’ own figures.
| Reaction | Frequency |
|---|---|
| Any adverse event during treatment | 66.4% vs 67.6% on placebo (1,089 adults with sepsis, seven days of dosing) |
Serious reactions to watch for
These are rarer, and they are the ones clinicians monitor for. Seek medical care if you have symptoms.
| Reaction | Frequency |
|---|---|
| Serious adverse event | 26.8% vs 29.3% on placebo (same trial) — no statistically significant difference |
| Serious adverse events attributed to the drug itself | None recorded in the earlier 361-participant severe-sepsis trial |
When to seek medical care
The trial report does not give a separate list of serious reactions. There is also no approved label. That gap does not mean serious reactions cannot happen. This compound has been studied in fewer people and for less time than an approved drug.
1Read deeper
When these effects tend to occur
The cited evidence describes these effects in relation to the dose and to the early period of taking it, rather than as a constant background throughout.
When a study reports how side effects changed over time, it describes the group as a whole. It cannot predict one person’s experience.
Common questions
How long do thymosin alpha-1 side effects last, and do they go away?
The sources do not commit to a set number of days. What they describe is a pattern — reactions cluster after you start and after each increase, then ease while the dose is held steady. Any page quoting an exact number of days is quoting something the sources do not say.
What are the most common thymosin alpha-1 side effects?
Any adverse event during treatment — the table above has the rest, each with its frequency band and source.
Does thymosin alpha-1 have a boxed warning?
No, because a boxed warning is part of an FDA-approved label and thymosin alpha-1 has no approved label. That reflects what regulatory review has and has not covered, not a finding that serious risks were looked for and ruled out.
Can the thymosin alpha-1 dose be lowered if side effects are hard to tolerate?
That decision belongs to the prescribing clinician. No approved schedule exists for this compound, so there is no labeled framework for adjusting a dose. That leaves the prescriber as the only place the decision can sit.
Does thymosin alpha-1 cause hair loss?
Hair loss is not among the reactions listed on this page for thymosin alpha-1, because the cited trial report cited here does not carry it. Anything missing from the tables is outside what can be sourced here rather than ruled out, and a symptom that worries you belongs with a clinician.
Is fatigue a listed thymosin alpha-1 side effect?
No — the cited trial report cited here does not list it. That describes what was reported, not proof that the symptom cannot happen.
Is constipation a listed thymosin alpha-1 side effect?
Not separately. If a source groups stomach and gut events together, this page keeps that group intact. It does not invent named reactions the source never listed.
What should someone do about a serious thymosin alpha-1 reaction?
Contact a clinician promptly, and emergency services if symptoms are severe or getting worse quickly. The section above describes what those reactions actually look like, so they can be spotted early rather than explained away.
Do the frequencies on this page mean the chance it happens to one person?
No. These figures describe groups in a study. A band shows how often a reaction appeared under that trial’s conditions. It cannot predict what will happen to one person.
Related
The schedule these reactions were recorded against, the comparisons, and the sourcing rules behind every grade on this page.
How Thymosin alpha-1 differs from the rest of its class
Doses per 5 mg Thymosin alpha-1 vial, on the calculator
The generic calculator behind the Thymosin alpha-1 one
Where Thymosin alpha-1 stands with the regulator, and when
The full index behind the Thymosin alpha-1 page
Why these Thymosin alpha-1 sources were chosen
Questions readers ask
Is thymosin alpha 1 safe to take?
How long should you take thymosin alpha 1?
What to stack with thymosin alpha 1?
Where to inject thymosin alpha 1?
- Wu J, et al. The efficacy and safety of thymosin alpha1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial. BMJ 2025;388:e082583retrieved 2026-08-12Human trial
- Wu J, et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care 2013;17(1):R8retrieved 2026-08-12Human trial